Pharmacophore modeling methods in focused library selection-applications in the context of a new classification scheme

Combinatorial Chemistry and High Throughput Screening

Volumn 14, Issue 6, 2011, Pages 488-499

  Luu, Tien T T ^a   Malcolm, Noj ^a   Nadassy, Katalin ^a  

^a Accelrys Limited UK   (United Kingdom)

Author keywords

Alignment; Feature abstraction; Feature comparison; Feature selection; Focused library; Lead identification; Pharmacophore

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID; MITOGEN ACTIVATED PROTEIN KINASE 14; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMICAL INTERACTION; MOLECULAR LIBRARY; MOLECULAR MODEL; PHARMACOPHORE; PRIORITY JOURNAL;

ANIMALS; COMPUTING METHODOLOGIES; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; SMALL MOLECULE LIBRARIES;

EID: 79957993168     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/138620711795767820     Document Type: Article

References (109)

1. Ehrlich, P. Über den jetzigen stand der chemotherapie. Berichte der deutschen chemischen Gesellschaft, 1909, 42(1), 17-47.
2. Wermuth, C. G.; Ganellin, C. R.; Lindberg, P.; Mitscher, L. A. Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1997). In Annu. Rep. Med. Chem., 33 ed.; Bristol, J. A., Ed. Academic Press: 1998; pp 385-395.
3. Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The conformational parameter in drug design: The active analog approach. In Computer-Assisted Drug Design, American Chemical Society: 1979; Vol. 112, pp 205-226.
4. (a) Güner, O. F. Pharmacophore Perception, Development, and use in Drug Design. International University Line: la Jolla, California, 2000;
5. (b) Mason, J. S.; Good, A. C.; Martin, E. J. 3-D pharmacophores in drug discovery. Curr. Pharm. Des., 2001, 7(7), 567-97; (Pubitemid 32427655)
6. (c) Van Drie, J. H. Pharmacophore Discovery - Lessons Learned. Curr. Pharm. Des., 2003, 9(20), 1649-64;
7. (d) Langer, T.; Hoffmann, R. D. Pharmacophores and Pharmacophore Searches. Wiley-VCH: Weinheim, Germany, 2006;
8. (e) Martin, Y. C. Pharmacophore Modeling: 1 - Methods. In Comprehensive Medicinal Chemistry II, Taylor, J. B.; Triggle, D. J.; Mason, J. S., Eds. Elsevier: Amsterdam, 2007; Vol. 4, pp 119-147;
9. (f) Martin, Y. C. Pharmacophore Modeling: 2 - Applications. In Comprehensive Medicinal Chemistry II, Taylor, J. B.; Triggle, D. J.; Mason, J. S., Eds. Elsevier: Amsterdam, 2007; Vol. 4, pp 515-536;
10. (g) Leach, A. R.; Gillet, V. J.; Lewis, R. A.; Taylor, R. Three-dimensional pharmacophore methods in drug discovery. J. Med. Chem., 2010, 53(2), 539-558;
11. (h) Yang, S. Y., Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov. Today, 2010, 15 (11/12), 444-450.
12. Villar, H. O.; Koehler, R. T. Comments on the design of chemical libraries for screening. Mol. Divers., 2000, 5(1), 13-24. (Pubitemid 32422188)
13. Hecker, E. A.; Duraiswami, C.; Andrea, T. A.; Diller, D. J. Use of Catalyst pharmacophore models for screening of large combinatorial libraries. J. Chem. Inf. Comput. Sci., 2002, 42(5), 1204-1211. (Pubitemid 35360306)
14. Dixon, S. L.; Smondyrev, A. M.; Knoll, E. H.; Rao, S. N.; Shaw, D. E.; Friesner, R. A. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J. Comput. Aided Mol. Des., 2006, 20 (10-11), 647-671. (Pubitemid 46023928)
15. SMARTS Theory Manual, Daylight Chemical Information Systems: Santa Fe, New Mexico, 2008.
16. (a) SYBYL-X, Tripos Inc.: 2010;
17. (b) Hurst, T. Flexible 3D searching: The directed tweak technique. J. Chem. Inf. Comput. Sci., 1994, 34(1), 190-196;
18. (c) Clark, D. E.; Jones, G.; Willett, P.; Kenny, P. W.; Glen, R. C. Pharmacophoric pattern matching in files of threedimensional chemical structures: Comparison of conformationalsearching algorithms for flexible searching. J. Chem. Inf. Comput. Sci., 1994, 34(1), 197-206.
19. (a) Ash, S.; Cline, M. A.; Homer, R. W.; Hurst, T.; Smith, G. B. SYBYL Line Notation (SLN): A Versatile language for chemical structure representation. J. Chem. Inf. Comput. Sci., 1997, 37(1), 71-79; (Pubitemid 127601580)
20. (b) Homer, R. W.; Swanson, J.; Jilek, R. J.; Hurst, T.; Clark, R. D. SYBYL line notation (SLN): a single notation to represent chemical structures, queries, reactions, and virtual libraries. J. Chem. Inf. Model., 2008, 48(12), 2294-2307.
21. (a) Discovery Studio, Accelrys Inc.: 2010;
22. (b) Greene, J.; Kahn, S.; Savoj, H.; Sprague, P.; Teig, S. Chemical function queries for 3D database search. J. Chem. Inf. Comput. Sci., 1994, 34(6), 1297-1308;
23. (c) Barnum, D.; Greene, J.; Smellie, A.; Sprague, P. Identification of common functional configurations among molecules. J. Chem. Inf. Comput. Sci., 1996, 36(3), 563-571. (Pubitemid 126539357)
24. Berezin, S.; Greene, J.; Kahn, S.; Ku, S.; Teig, S. In CHM: A Chemically expressive database query language, 9th Noordwijkerhout Camerino Medicinal Chemistry Symposium, Noordwijkerhout, The Netherlands, Noordwijkerhout, The Netherlands, 1993.
25. Baroni, M.; Cruciani, G.; Sciabola, S.; Perruccio, F.; Mason, J. S. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application. J. Chem. Inf. Model., 2007, 47(2), 279-294. (Pubitemid 46615933)
26. Kirchhoff, P. D.; Brown, R.; Kahn, S.; Waldman, M.; Venkatachalam, C. M. Application of structure-based focusing to the estrogen receptor. J. Comput. Chem., 2001, 22(10), 993-1003. (Pubitemid 32614371)
27. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem., 1985, 28(7), 849-57. (Pubitemid 15012490)
28. ParaSurf, Cepos InSilico Limited: 2010.
29. Cross, S.; Cruciani, G. Molecular fields in drug discovery: getting old or reaching maturity? Drug Discov. Today, 2010, 15 (1-2), 23-32.
30. MOE, Chemical Computing Group: 2010.
31. Li, H.; Sutter, J.; Hoffmann, R. HypoGen: An Automated System for Generating 3D Predictive Pharmacophore Models. In Pharmacophore Perception, Development, and use in Drug Design, Güner, O. F., Ed. International University Line: la Jolla, California, 2000; pp 171-189.
32. Jenkins, J. L.; Glick, M.; Davies, J. W. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. J. Med. Chem., 2004, 47(25), 6144-6159. (Pubitemid 39587240)
33. Martin, Y. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput. Aided Mol. Des., 1993, 7(1), 83-102.
34. Jones, G.; Willett, P.; Glen, R. C. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comput Aided Mol. Des., 1995, 9(6), 532-549.
35. Nicholls, A.; McGaughey, G. B.; Sheridan, R. P.; Good, A. C.; Warren, G.; Mathieu, M.; Muchmore, S. W.; Brown, S. P.; Grant, J. A.; Haigh, J. A.; Nevins, N.; Jain, A. N.; Kelley, B. Molecular shape and medicinal chemistry: a perspective. J. Med. Chem., 2010, 53(10), 3862-3886.
36. Van Drie, J. H.; Weininger, D.; Martin, Y. C. ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures. J. Comput. Aided Mol. Des., 1989, 3(3), 225-251.
37. Golender, V.; Vorpagel, E. Computer-Assisted Pharmacophore Identification. In 3D QSAR in Drug Design: Theory, Methods and Applications, Kubinyi, H., Ed. ESCOM Science Publishers: Netherlands, 1993; pp 137-149.
38. Snyder, J. P.; Rao, S. N.; Koehler, K. F.; Vedani, A.; Pelliciari, R. APOLLO Pharmacophores and the pseudoreceptor concept. In Trends in QSAR and Molecular Modeling, Wermuth, C. G., Ed. ESCOM: Leiden, 1993; pp 44-51.
39. Dolata, D. P.; Parrill, A. L.; Walters, W. P. CLEW: The generation of pharmacophore hypotheses through machine learning. SAR QSAR Environ. Res., 1998, 9(1), 53-81.
40. Rhodes, N.; Willett, P.; Calvet, A.; Dunbar, J. B.; Humblet, C. CLIP: similarity searching of 3D databases using clique detection. J. Chem. Inf. Comput. Sci., 2003, 43(2), 443-448.
41. Kramer, A.; Horn, H. W.; Rice, J. E. Fast 3D molecular superposition and similarity search in databases of flexible molecules. J. Comput.-Aided Mol. Des., 2003, 17(1), 13-38. (Pubitemid 36939538)
42. (a) Richmond, N. J.; Abrams, C. A.; Wolohan, P. R.; Abrahamian, E.; Willett, P.; Clark, R. D. GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D. J. Comput. Aided Mol. Des., 2006, 20(9), 567-587; (Pubitemid 44823892)
43. (b) Clark, R. D.; Abrahamian, E. Using a staged multi-objective optimization approach to find selective pharmacophore models. In J. Comput.-Aided Mol. Des., Springer Netherlands: 2009; Vol. 23, pp 765-771.
44. We classify GALAHAD as an alignment-based method, as this is how the comparison of test ligands is performed with respect to the model. However, the use of 3D fingerprints is a key step in conformer selection when building the models.
45. (a) Wolber, G.; Langer, T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model., 2005, 45(1), 160-169; (Pubitemid 40736968)
46. (b) Wolber, G.; Seidel, T.; Bendix, F.; Langer, T. Moleculepharmacophore superpositioning and pattern matching in computational drug design. Drug Discov. Today, 2008, 13 (1-2), 23-29.
47. Podolyan, Y.; Karypis, G. Common pharmacophore identification using frequent clique detection algorithm. J. Chem. Inf. Model., 2008, 49(1), 13-21.
48. Cottrell, S. J.; Gillet, V. J.; Taylor, R.; Wilton, D. J., Generation of multiple pharmacophore hypotheses using multiobjective optimisation techniques. J. Comput.-Aided Mol. Des., 2004, 18(11), 665-682. (Pubitemid 40425038)
49. Taminau, J.; Thijs, G.; De Winter, H. Pharao: pharmacophore alignment and optimization. J. Mol. Graphics Model., 2008, 27(2), 161-169.
50. Inbar, Y.; Schneidman-Duhovny, D.; Dror, O.; Nussinov, R.; Wolfson, H. J., Deterministic Pharmacophore Detection via Multiple Flexible Alignment of Drug-Like Molecules. In Proc. of RECOMB 2007, Springer Verlag: 2007; Vol. 3692, pp 423-434.
51. Feng, J.; Sanil, A.; Young, S. S. PharmID: Pharmacophore identification using Gibbs sampling. J. Chem. Inf. Model., 2006, 46(3), 1352-1359. (Pubitemid 43999178)
52. Finn, P.; Muggleton, S.; Page, D.; Srinivasan, A. Pharmacophore discovery using the inductive logic programming system PROGOL. Machine Learning, 1998, 30(2), 241-270.
53. Todorov, N. P.; Alberts, I. L.; de Esch, I. J.; Dean, P. M. QUASI: a novel method for simultaneous superposition of multiple flexible ligands and virtual screening using partial similarity. J. Chem. Inf. Model., 2007, 47(3), 1007-1020. (Pubitemid 46973716)
54. Finn, P. W.; Kavraki, L. E.; Latombe, J.-C.; Motwani, R.; Shelton, C.; Venkatasubramanian, S.; Yao, A. RAPID: Randomized pharmacophore identification for drug design. Computational Geometry, 1998, 10(4), 263-272. (Pubitemid 128401868)
55. Chen, X.; Rusinko, A., 3rd.; Tropsha, A.; Young, S. S. Automated pharmacophore identification for large chemical data sets. J. Chem. Inf. Comput. Sci., 1999, 39(5), 887-896.
56. Totrov, M. Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR. Chem. Biol. Drug Des., 2008, 71(1), 15-27.
57. Mills, J. E.; de Esch, I. J.; Perkins, T. D.; Dean, P. M. SLATE: a method for the superposition of flexible ligands. J. Comput.-Aided Mol. Des., 2001, 15(1), 81-96. (Pubitemid 32124161)
58. Bandyopadhyay, D.; Agrafiotis, D. K. A self-organizing algorithm for molecular alignment and pharmacophore development. J. Comput. Chem., 2008, 29(6), 965-982. (Pubitemid 351473693)
59. THINK, Treweren Consultants Ltd.: 2010.
60. (a) Cheeseright, T.; Mackey, M.; Rose, S.; Vinter, A. Molecular field extrema as descriptors of biological activity: definition and validation. J. Chem. Inf. Model., 2006, 46(2), 665-676;
61. (b) Cheeseright, T. J.; Mackey, M. D.; Melville, J. L.; Vinter, J. G. FieldScreen: virtual screening using molecular fields. Application to the DUD data set. J. Chem. Inf. Model., 2008, 48(11), 2108-2117.
62. Kalliokoski, T.; Ronkko, T.; Poso, A. FieldChopper, a new tool for automatic model generation and virtual screening based on molecular fields. J. Chem. Inf. Model., 2008, 48(6), 1131-1137.
63. Melani, F.; Gratteri, P.; Adamo, M.; Bonaccini, C. Field interaction and geometrical overlap: a new simplex and experimental design based computational procedure for superposing small ligand molecules. J. Med. Chem., 2003, 46(8), 1359-1371. (Pubitemid 36512700)
64. Ortuso, F.; Langer, T.; Alcaro, S. GBPM: GRID-based pharmacophore model: concept and application studies to proteinprotein recognition. Bioinformatics, 2006, 22(12), 1449-1455. (Pubitemid 43985315)
65. Chen, J.; Lai, L. Pocket v. 2: further developments on receptorbased pharmacophore modeling. J. Chem. Inf. Model., 2006, 46(6), 2684-2691. (Pubitemid 46008137)
66. Bonachera, F.; Parent, B.; Barbosa, F.; Froloff, N.; Horvath, D. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes. J. Chem. Inf. Model., 2006, 46(6), 2457-2477. (Pubitemid 46008118)
67. Lounkine, E.; Hu, Y.; Batista, J.; Bajorath, J. Relevance of feature combinations for similarity searching using general or activity class-directed molecular fingerprints. J. Chem. Inf. Model., 2009, 49(3), 561-570.
68. Fechner, U.; Franke, L.; Renner, S.; Schneider, P.; Schneider, G. Comparison of correlation vector methods for ligand-based similarity searching. J. Comput. Aided Mol. Des., 2003, 17(10), 687-698. (Pubitemid 38344471)
69. Murrall, N. W.; Davies, E. K. Conformational freedom in 3-D databases. 1. Techniques. J. Chem. Inf. Comput. Sci., 1990, 30(3), 312-316.
70. Rogers, D.; Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model., 2010, 50(5), 742-754.
71. von Korff, M.; Freyss, J.; Sander, T. Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility. J. Chem. Inf. Model., 2008, 48(4), 797-810. (Pubitemid 351757745)
72. Catana, C. Simple idea to generate fragment and pharmacophore descriptors and their implications in chemical informatics. J. Chem. Inf. Model., 2009, 49(3), 543-548.
73. Hessler, G.; Zimmermann, M.; Matter, H.; Evers, A.; Naumann, T.; Lengauer, T.; Rarey, M. Multiple-ligand-based virtual screening: methods and applications of the MTree approach. J. Med. Chem., 2005, 48(21), 6575-6584. (Pubitemid 41504715)
74. Martin, E. J.; Hoeffel, T. J. Oriented substituent pharmacophore PRopErtY space (OSPPREYS): a substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation. J. Mol. Graphics Model. 2000, 18 (4-5), 383-403.
75. Pipeline Pilot, Accelrys Inc: 2010.
76. Sato, T.; Honma, T.; Yokoyama, S. Combining machine learning and pharmacophore-based interaction fingerprint for in silico screening. J. Chem. Inf. Model., 2010, 50(1), 170-185.
77. McGregor, M. J.; Muskal, S. M. Pharmacophore fingerprinting. 1. Application to QSAR and focused library design. J. Chem. Inf. Comput. Sci., 1999, 39(3), 569-574. (Pubitemid 129539215)
78. Hahnke, V.; Hofmann, B.; Grgat, T.; Proschak, E.; Steinhilber, D.; Schneider, G., PhAST: pharmacophore alignment search tool. J. Comput. Chem., 2009, 30(5), 761-771.
79. Screen, ChemAxon Kft: 2010.
80. Deng, Z.; Chuaqui, C.; Singh, J. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional proteinligand binding interactions. J. Med. Chem., 2004, 47(2), 337-344. (Pubitemid 38057878)
81. Renner, S.; Schneider, G. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening. J. Med. Chem., 2004, 47(19), 4653-4664. (Pubitemid 39195556)
82. Abrahamian, E.; Fox, P. C.; Naerum, L.; Christensen, I. T.; Thogersen, H.; Clark, R. D. Efficient generation, storage, and manipulation of fully flexible pharmacophore multiplets and their use in 3-D similarity searching. J. Chem. Inf. Comput. Sci., 2003, 43(2), 458-468.
83. Makara, G. M. Measuring molecular similarity and diversity: total pharmacophore diversity. J. Med. Chem., 2001, 44(22), 3563-3571. (Pubitemid 33026663)
84. Kabsch, W. A discussion of the solution for the best rotation to relate two sets of vectors. Acta Crystallogr. Sect. A: Found. Crystallogr., 1978, 34(5), 827-828.
85. Lee, B.; Richards, F. M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol., 1971, 55(3), 379-400.
86. Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D. Biol. Crystallogr., 1994, 50 (Pt 5), 760-763.
87. (a) Vinter, J. G. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions. J. Comput. Aided Mol. Des., 1994, 8(6), 653-668;
88. (b) Vinter, J. G. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions. II. Organic complexes. J. Comput. Aided Mol. Des., 1996, 10(5), 417-426. (Pubitemid 126712438)
89. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem., 1985, 28(7), 849-857. (Pubitemid 15012490)
90. Wang, H.; Duffy, R. A.; Boykow, G. C.; Chackalamannil, S.; Madison, V. S. Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model. J. Med. Chem., 2008, 51(8), 2439-2446. (Pubitemid 351628505)
91. MacroModel, Schrödinger LLC: 2010.
92. MDDR database, Accelrys Inc.: 2010.
93. Kumar, A.; Chaturvedi, V.; Bhatnagar, S.; Sinha, S.; Siddiqi, M. I. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints. J. Chem. Inf. Model., 2008, 49(1), 35-42.
94. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 1996, 261(3), 470-489. (Pubitemid 26335901)
95. Cheeseright, T. J.; Holm, M.; Lehmann, F.; Luik, S.; Gottert, M.; Melville, J. L.; Laufer, S. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J. Med. Chem., 2009, 52(14), 4200-1209.
96. Carosati, E.; Cruciani, G.; Chiarini, A.; Budriesi, R.; Ioan, P.; Spisani, R.; Spinelli, D.; Cosimelli, B.; Fusi, F.; Frosini, M.; Matucci, R.; Gasparrini, F.; Ciogli, A.; Stephens, P. J.; Devlin, F. J. Calcium channel antagonists discovered by a multidisciplinary approach. J. Med. Chem., 2006, 49(17), 5206-5216. (Pubitemid 44260216)
97. (a) Buckley, M. M.; Grant, S. M.; Goa, K. L.; McTavish, D.; Sorkin, E. M. Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs, 1990, 39(5), 757-806;
98. (b) Grossman, E.; Messerli, F. H. Calcium antagonists. Prog. Cardiovasc. Dis., 2004, 47(1), 34-57. (Pubitemid 39420271)
99. Budriesi, R.; Cosimelli, B.; Ioan, P.; Lanza, C. Z.; Spinelli, D.; Chiarini, A. Cardiovascular characterization of [1,4]thiazino[3,4-c][1,2,4] oxadiazol-1-one derivatives: selective myocardial calcium channel modulators. J. Med. Chem., 2002, 45(16), 3475-3481. (Pubitemid 34824035)
100. Kawai, C.; Konishi, T.; Matsuyama, E.; Okazaki, H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation, 1981, 63(5), 1035-1042. (Pubitemid 11106369)
101. Zhou, S.; Chan, E.; Lim, L. Y.; Boelsterli, U. A.; Li, S. C.; Wang, J.; Zhang, Q.; Huang, M.; Xu, A. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr. Drug Metab., 2004, 5(5), 415-442. (Pubitemid 39276605)
102. The overall library consisted of 198160 compounds from Sigma-Aldrich Inc. (http://www.sigmaaldrich.com), 47401
103. from Key Organics Ltd. (http://www.keyorganics.ltd.uk), 83286
104. from Maybridge Chemicals (http://www.maybridge.com), 5017
105. from Menai Organics Ltd. (http://www.ryansci.com)
106. and 8548 from Peakdale Molecular (http://www.peakdale.co.uk).
107. Jacoby, E.; Boettcher, A.; Mayr, L. M.; Brown, N.; Jenkins, J. L.; Kallen, J.; Engeloch, C.; Schopfer, U.; Furet, P.; Masuya, K.; Lisztwan, J. Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction. Meth. Mol. Biol., 2009, 575, 173-194.
108. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47(7), 1739-1749. (Pubitemid 38380917)
109. Beroza, P.; Bradley, E. K.; Eksterowicz, J. E.; Feinstein, R.; Greene, J.; Grootenhuis, P. D.; Henne, R. M.; Mount, J.; Shirley, W. A.; Smellie, A.; Stanton, R. V.; Spellmeyer, D. C. Applications of random sampling to virtual screening of combinatorial libraries. J. Mol. Graphics Model., 2000, 18 (4-5), 335-342.